Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Strang

Showing results (81-90 of 301) with videos related to

Pageof 31
Sort By:
The Practitioner|December 13, 2005
The GP's role in opiate misuseNat Wright, Jenny Keen, Clare Gerada, et al.
BMJ (Clinical Research Ed.)|February 11, 2003
General practitioner screening for excessive alcohol use. General practitioners' experiences are importantJim McCambridge, Francis Keaney, John Strang, et al.
Addiction (Abingdon, England)|January 17, 2022
Could COVID expand the future of addiction research? Long-term implications in the pandemic eraAmir Englund, Stephen Sharman, Basak Tas, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 7, 2003
Cannabis use and the GP: brief motivational intervention increases clinical enquiry by GPs in a pilot studyJim McCambridge, John Strang, Simon Platts, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 7, 2017
Supervised Injectable Heroin: A Clinical PerspectiveJames Bell, Rob van der Waal, John Strang
Drug and Alcohol Review|May 28, 2019
Depot buprenorphine injections for opioid use disorder: Patient information needs and preferencesJoanne Neale, Charlotte N E Tompkins, John Strang
Diagnostic and Prognostic Research|April 15, 2024
The development and internal validation of a multivariable model predicting 6-month mortality for people with opioid use disorder presenting to community drug services in England: a protocolEmmert Roberts, John Strang, Patrick Horgan, et al.
Drug and Alcohol Review|November 26, 2009
Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin useRichard Senbanjo, Kim Wolff, E Jane Marshall, et al.
Drugs (Abingdon, England)|June 6, 2015
Take-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland's public health policy evaluation, and a new measure to assess impactSheila M Bird, Mahesh K B Parmar, John Strang
Drug and Alcohol Review|June 10, 2017
International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope databaseRebecca McDonald, Øyvind Danielsson Glende, Ola Dale, et al.
Pageof 31

Showing results (81-90 of 301) with videos related to

Sort By:
Pageof 31
The Practitioner|December 13, 2005
The GP's role in opiate misuseNat Wright, Jenny Keen, Clare Gerada, et al.
BMJ (Clinical Research Ed.)|February 11, 2003
General practitioner screening for excessive alcohol use. General practitioners' experiences are importantJim McCambridge, Francis Keaney, John Strang, et al.
Addiction (Abingdon, England)|January 17, 2022
Could COVID expand the future of addiction research? Long-term implications in the pandemic eraAmir Englund, Stephen Sharman, Basak Tas, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 7, 2003
Cannabis use and the GP: brief motivational intervention increases clinical enquiry by GPs in a pilot studyJim McCambridge, John Strang, Simon Platts, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 7, 2017
Supervised Injectable Heroin: A Clinical PerspectiveJames Bell, Rob van der Waal, John Strang
Drug and Alcohol Review|May 28, 2019
Depot buprenorphine injections for opioid use disorder: Patient information needs and preferencesJoanne Neale, Charlotte N E Tompkins, John Strang
Diagnostic and Prognostic Research|April 15, 2024
The development and internal validation of a multivariable model predicting 6-month mortality for people with opioid use disorder presenting to community drug services in England: a protocolEmmert Roberts, John Strang, Patrick Horgan, et al.
Drug and Alcohol Review|November 26, 2009
Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin useRichard Senbanjo, Kim Wolff, E Jane Marshall, et al.
Drugs (Abingdon, England)|June 6, 2015
Take-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland's public health policy evaluation, and a new measure to assess impactSheila M Bird, Mahesh K B Parmar, John Strang
Drug and Alcohol Review|June 10, 2017
International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope databaseRebecca McDonald, Øyvind Danielsson Glende, Ola Dale, et al.
Pageof 31